The IperionX Ltd (ASX: IPX) share price is in focus after the company completed commissioning of its Virginia Titanium Manufacturing Campus and ended the December quarter with a strong US$65.8 million cash balance.
Image source: Getty Images
What did IperionX report?
- Equipment for titanium powder and component production fully commissioned at the Virginia Titanium Manufacturing Campus
- Manufacturing capacity expansion on track, with target of 1,400 tons per annum (tpa) by 2027
- Initial sales orders received from Carver Pump and American Rheinmetall for titanium components
- US$47.1 million US Department of War grant fully obligated, aiding expansion plans
- US$65.8 million in cash at quarter-end, with US$46.5 million in grant funding still available
- ISO 9001 quality certification achieved for manufacturing operations
What else do investors need to know?
The company has commenced building inventory for mass distribution, including a range of titanium fasteners for commercial and U.S. military customers. IperionX continues advanced prototyping for industries like defense, electronics, automotive, and oil & gas, highlighting growing commercial activity.
Progress was also made at the Titan Critical Minerals Project in Tennessee. Backed by U.S. Government interest and funding, IperionX aims to help address the nation's supply gap for critical minerals, including heavy rare earths and titanium needed in defence and clean energy applications.
Federal Government support remains a key pillar, with the U.S. transferring around 290 tons of titanium scrap to IperionX at no cost, securing feedstock for about 1.5 years at current capacity.
What's next for IperionX?
IperionX plans to scale titanium production to 1,400 tpa by 2027, targeting market leadership as America's largest and lowest-cost titanium powder producer. Additional presses and furnaces arriving in 2026 will support this capacity ramp-up.
The company is also piloting next-generation, continuous titanium production technology, aiming for completion in 2026. Meanwhile, a Definitive Feasibility Study for the Titan Critical Minerals Project remains on schedule, with completion targeted for mid-2026.
IperionX share price snapshot
Over the past 12 months, IperionX shares have risen 90% outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 5% over the same period.
